Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Anton Camaj

Interventional Cardiology New York, NY Medical Doctor

NPI 1417489089 CMS profile 8800418

1111 Amsterdam Ave, New York, NY 10025

Open in the dashboard

General payments

$76,352

402 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anton Camaj of New York, NY is reported in the CMS Open Payments database as having received $76,352 across 402 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,110 81
2024 General $48,078 146
2023 General $18,784 115
2022 General $666 20
2021 General $1,262 31
2020 General $452 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anton Camaj
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Anton Camaj were reported at $7,110. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Anton Camaj Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $452 $473 $161–$1,480 $114
2021 $1,262 $677 $233–$1,827 $132
2022 $666 $978 $333–$2,724 $149
2023 $18,784 $1,136 $382–$2,986 $160
2024 $48,078 $1,181 $395–$3,326 $164
2025 $7,110 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Abbott Laboratories $44,436 61 payments
  2. Medtronic, Inc. $17,374 32 payments
  3. Edwards Lifesciences Corporation $3,859 44 payments
  4. Shockwave Medical, Inc $2,154 44 payments
  5. AstraZeneca Pharmaceuticals LP $1,650 32 payments
  6. Boston Scientific Corporation $745 18 payments
  7. Cardiovascular Systems Inc. $743 23 payments
  8. Terumo Medical Corporation $726 22 payments
  9. W. L. Gore & Associates, Inc. $637 7 payments
  10. Abiomed $501 16 payments
  11. Other $3,527 103 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Grant $57,000 3 payments
  2. Food and Beverage $16,922 386 payments
  3. Travel and Lodging $2,149 10 payments
  4. Consulting Fee $200 1 payment
  5. Education $81 2 payments
Products named General payments · program years 2020–2025
  1. MITRACLIP $27,000 1 payment
  2. COREVALVE EVOLUT R $16,767 20 payments
  3. SAPIEN 3 Ultra RESILIA $2,268 31 payments
  4. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $2,013 42 payments
  5. FARXIGA $680 18 payments
  6. GORE CARDIOFORM Septal Occluder $637 7 payments
  7. Diamondback Coronary $594 20 payments
  8. Impella $501 16 payments
  9. BRILINTA $483 6 payments
  10. KENGREAL $444 19 payments
  11. Other $8,324 208 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

402 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record